<DOC>
	<DOCNO>NCT00721214</DOCNO>
	<brief_summary>The purpose study examine feasibility efficacy use demethylating agent 5-Azacytidine prior allogeneic stem cell transplantation patient high risk myelodysplastic syndrome ( MDS ) .</brief_summary>
	<brief_title>5-Azacytidine Prior Allogeneic Stem Cell Transplant High Risk Myelodysplastic Syndrome</brief_title>
	<detailed_description>The study drug , 5-azacytidine , give daily intravenously 7 day . After every 2 cycle study participant bone marrow test evaluate effect 5-azacytidine Myelodysplastic Syndrome ( MDS ) . Participants continue get cycle 5-Azacytidine 2 bone marrow test show MDS stop respond treatment . At time undergo transplant donor available .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<criteria>Patients fulfil follow criterion eligible study entry : 1 . Diagnosis MDS accord WHO criteria 2 . Intermediate2 high risk IPSS score 3 . Clinically able receive 5Azacytidine 4 . Serum bilirubin level &lt; /=1.5 time upper limit normal range laboratory ( ULN ) . Higher level acceptable attribute active hemolysis ineffective erythropoiesis 5 . Serum glutamicoxaloacetic transaminase ( SGOT ) serum glutamicpyruvic transaminase ( SGPT ) level &lt; /=2 x ULN 6 . Serum creatinine level &lt; /=1.5 x ULN 7 . Negative serum pregnancy test prior 5Azacytidine treatment woman childbearing potential 8 . Women men childbearing potential agree use contraception receive treatment 5Azacytidine 9 . Potentially eligible allogeneic transplantation 10 . No prior allogeneic transplant 11 . Age 18 70 , inclusive . 1 . Known suspected hypersensitivity 5azacytidine mannitol 2 . Patients previously treat 5azacytidine deoxyazacytidine 3 . Pregnant breast feed 4 . Patients advance malignant hepatic tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Myelodysplastic Syndrome</keyword>
	<keyword>5-azacytidine</keyword>
	<keyword>allogeneic stem cell transplantation</keyword>
</DOC>